Print Get Citation Citation Disclaimer: These citations have been automatically generated based on the information we have and it may not be 100% accurate. Please consult the latest official manual style if you have any questions regarding the format accuracy. AMA Citation Davis R, Chan A. Davis R, & Chan A Davis, Rhianna, and Alex Chan. SARS-CoV-2 infection may increase risk of prediabetes progression into diabetes. 2 Minute Medicine, 15 June 2023. McGraw Hill, 2023. AccessSurgery. https://accesssurgery.mhmedical.com/updatesContent.aspx?gbosid=626980§ionid=279127589APA Citation Davis R, Chan A. Davis R, & Chan A Davis, Rhianna, and Alex Chan. (2023). Sars-cov-2 infection may increase risk of prediabetes progression into diabetes. (2023). 2 minute medicine. McGraw Hill. https://accesssurgery.mhmedical.com/updatesContent.aspx?gbosid=626980§ionid=279127589.MLA Citation Davis R, Chan A. Davis R, & Chan A Davis, Rhianna, and Alex Chan. "SARS-CoV-2 infection may increase risk of prediabetes progression into diabetes." 2 Minute Medicine McGraw Hill, 2023, https://accesssurgery.mhmedical.com/updatesContent.aspx?gbosid=626980§ionid=279127589. Download citation file: RIS (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley © Copyright Annotate Clip Autosuggest Results SARS-CoV-2 infection may increase risk of prediabetes progression into diabetes by Rhianna Davis, Alex Chan Listen +Originally published by 2 Minute Medicine® (view original article). Reused on AccessMedicine with permission. +1. Patients with pre-diabetes who were hospitalized with COVID-19 had a greater risk of developing type-2 diabetes mellitus, compared to hospitalized pre-diabetic patients without COVID-19. +Evidence Rating Level: 2 (Good) +Recent observations and case reports have suggested an increased risk of developing new-onset type-2 diabetes (T2D) following COVID-19 infection. Researchers aimed to determine the incidence of new-onset diabetes following COVID-19 infection for participants with preexisting prediabetes. Data were collected from medical records using the Montefiore Health System in Bronx, New York. Researchers compared 42,877 patients with COVID-19 and a history of pre-diabetes to a propensity-matched group of 9306 pre-diabetic patients without COVID-19. Two primary outcomes were assessed: the incidence of new-onset in-hospital DM and new-onset persistent DM at a 5-month follow-up. Compared to hospitalized patients without COVID-19, hospitalized patients with COVID-19 had a greater incidence of new-onset DM (21.9% vs 6.02%, p<0.001) and persistent DM (14.75% vs 7.51%, p<0.001). The same trend was not observed for non-hospitalized patients. Researchers postulate that the physical and mental stress of hospitalization, as well as the steroids used to treat severe COVID-19 infections, may contribute to the development of DM. This study demonstrates that patients with pre-diabetes who are hospitalized for COVID-19 may benefit from more careful surveillance of their glycemic control. +Click to read the study in BMJ +©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.